Dr. Lam is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2700 Stockton Blvd
Sacramento, CA 95817Phone+1 916-734-0910Fax+1 916-734-7946- Is this information wrong?
Education & Training
University of Arizona College of Medicine-TucsonFellowship, Hematology and Medical Oncology, 1987 - 1989- University of Arizona College of Medicine-TucsonResidency, Internal Medicine, 1984 - 1987
Stanford University School of MedicineClass of 1984
Certifications & Licensure
CA State Medical License 1999 - 2021
Publications & Presentations
PubMed
- 1 citationsProtocol for vision transformer-based evaluation of drug potency using images processed by an optimized Sobel operator.Yongheng Wang, Weidi Zhang, Yi Wu, Chuyuan Qu, Hongru Hu, Teresa Lee, Siyu Lin, Jiawei Zhang, Kit S Lam, Aijun Wang> ;STAR Protocols. 2023 May 1
- 1 citationsSIC50: Determining drug inhibitory concentrations using a vision transformer and an optimized Sobel operator.Yongheng Wang, Weidi Zhang, Hoyin Yip, Chuyuan Qu, Hongru Hu, Xiaotie Chen, Teresa Lee, Xi Yang, Bingjun Yang, Priyadarsini Kumar, Su Yeon Lee, Javier J Casimiro, Jiaw...> ;Patterns. 2023 Feb 10
- 1 citationsBioinspired Screening of Anti-Adhesion Peptides against Blood Proteins for Intravenous Delivery of Nanomaterials.Yi-Jing Li, Lingze Zhang, Pei-Pei Yang, Kuo Zhang, Xue-Feng Gong, Da-Yong Hou, Hui Cao, Xiao-Chun Wu, Ruiwu Liu, Kit S Lam, Lei Wang> ;Nano Letters. 2022 Oct 26
- Join now to see all
Press Mentions
New Center for Experimental Therapeutics in Cancer Advances Promising TreatmentsOctober 7th, 2022- Process Mass Intensity (PMI): A Holistic Analysis of Current Peptide Manufacturing Processes Informs Sustainability in Peptide SynthesisMarch 26th, 2024
Grant Support
- Discovery Of Ligands For Directed-Differentiation Of Stem CellsNational Heart, Lung, And Blood Institute2012
- Multi-Functional Nanocarrier Against Canine LymphomaNational Institute Of Biomedical Imaging And Bioengineering2011–2012
- Therapeutic Targeting Agents For Ovarian CancerNational Cancer Institute2005–2012
- High Affinity Capturing Agents For StrychnineNational Institute Of Neurological Disorders And Stroke2010–2011
- Feasibility Of Nanoparticle-Mediated Paclitaxel DeliveryNational Center For Research Resources2010–2011
- Dna-Modulated Release Of Drug From Melanoma Targeting NPNational Cancer Institute2008–2009
- Optimization And Characterization Of Targeting Agents For Lymphoid MalignanciesNational Cancer Institute2007–2009
- High Affinity Ligand To Deliver Nanoparticle Drugs To Lymphoid CancersNational Cancer Institute2007–2009
- Targeting Agents For Human And Canine LymphomaNational Cancer Institute2005–2009
- C-SRC Inhibitors From Novel Encoded Chemical LibrariesNational Cancer Institute2003–2007
- Optimization And Characterization Of Targeting AgentsNational Cancer Institute2005–2006
- Combinatorial Peptide Libraries For Biodegradable Linkers To Decrease Normal TissNational Cancer Institute2004–2006
- Administrative CoreNational Cancer Institute2005
- Protein Kinase Specific PET Imaging Agent For CancerNational Cancer Institute2004–2005
- Small Molecule Microarrays For Intracellular ProteinsNational Cancer Institute2003–2005
- UC Davis AP4 CenterNational Cancer Institute2004
- Peptide Microarray For Cancer Cell Surface ReceptorsNational Institute Of Biomedical Imaging And Bioengineering2003
- Peptide Microarray For Cancer Cell Surface ReceptorsNational Cancer Institute2001–2002
- Ligands For Altered Phosphoproteins In CancerNational Cancer Institute2000–2002
- Peptide Substrate For Unique Protein Kinase In TissueNational Cancer Institute1999–2000
- Novel Antibiotics For Vancomycin Resistant InfectionNational Institute Of Allergy And Infectious Diseases1999
- Peptide Ligand For Altered Protein In Disease TissuesNational Cancer Institute1999
- Identification Of Small Molecule Inhibitors Of Protein Tyrosine KinaseNational Center For Research Resources1998–1999
- Peptide Substrate For Unique Protein Kinase In TissueNational Cancer Institute1998
- Peptide Ligand For Altered Protein In Disease TissuesNational Cancer Institute1998
- Novel Antibiotics For Vancomycin Resistant InfectionNational Institute Of Allergy And Infectious Diseases1997–1998
- Molecular Screening Of Cancer-Associated ReceptorsNational Cancer Institute1992–1994
Hospital Affiliations
UC Davis Medical CenterSacramento, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
